Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Personics Holdings Inc. is a medical technology company specializing in advanced hearing health and audio enhancement solutions. The company is best known for its proprietary Ambrose Diaphonic Ear Lens (ADEL) technology, which functions as a synthetic "second eardrum" to alleviate harmful pneumatic pressure in the ear canal caused by standard earbuds. This technology aims to prevent noise-induced hearing loss and tinnitus while significantly improving sound quality for both consumers and professionals. Personics primarily operates through research, development, and licensing its patented technologies to major audio manufacturers and hearing aid companies. By addressing the physiological impact of acoustic pressure, the company provides a unique approach to auditory safety in the consumer, professional, and industrial markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Personics.